Enhanced carbonyl stress and disrupted white matter integrity in schizophrenia
- PMID: 32843203
- DOI: 10.1016/j.schres.2020.08.007
Enhanced carbonyl stress and disrupted white matter integrity in schizophrenia
Abstract
Carbonyl stress is a state caused by an increase in rich reactive carbonyl compounds (RCOs); RCOs facilitate the formation of advanced glycation end products (AGEs), which are associated with various age-related illnesses. Recently, enhanced carbonyl stress and lower levels of pyridoxal, a kind of vitamin B6 that scavenges RCOs, have been shown to be associated with schizophrenia. Meanwhile, lower levels of pyridoxal have been reported to decrease myelination through the biochemical process of carbonyl stress. Despite a number of reports on white matter disruption in schizophrenia, it is unclear whether this disruption is related to enhanced carbonyl stress. Therefore, we investigated the relationship between carbonyl stress and white matter integrity in schizophrenia using diffusion tensor imaging. A total of 53 patients with schizophrenia and 83 age- and gender-matched healthy controls were recruited. We used plasma pentosidine, an AGE, and serum pyridoxal as carbonyl stress markers. Between-group differences in these carbonyl stress markers and their relationships with white matter integrity were investigated using Tract-Based Spatial Statistics. In the schizophrenia group, plasma pentosidine level was significantly higher and serum pyridoxal level was lower than those of controls. There was a significant negative correlation between plasma pentosidine and white matter integrity in the schizophrenia group, but not in the control group. Our findings suggest that enhanced carbonyl stress is a possible underlying mechanism of white matter microstructural disruption in schizophrenia.
Keywords: Advanced glycation end products (AGEs); Carbonyl stress; Pentosidine; Pyridoxal; Schizophrenia.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflicts of interest.
Similar articles
-
Association between enhanced carbonyl stress and decreased apparent axonal density in schizophrenia by multimodal white matter imaging.Sci Rep. 2023 Jul 27;13(1):12220. doi: 10.1038/s41598-023-39379-w. Sci Rep. 2023. PMID: 37500709 Free PMC article.
-
Enhanced carbonyl stress in a subpopulation of schizophrenia.Arch Gen Psychiatry. 2010 Jun;67(6):589-97. doi: 10.1001/archgenpsychiatry.2010.62. Arch Gen Psychiatry. 2010. PMID: 20530008
-
[Carbonyl stress-related schizophrenia--perspective on future therapy and hypotheses regarding pathophysiology of schizophrenia].Seishin Shinkeigaku Zasshi. 2012;114(3):199-208. Seishin Shinkeigaku Zasshi. 2012. PMID: 22568054 Review. Japanese.
-
[Schizophrenia and carbonyl stress].Seishin Shinkeigaku Zasshi. 2012;114(2):101-7. Seishin Shinkeigaku Zasshi. 2012. PMID: 22568112 Japanese.
-
Carbonyl stress and schizophrenia.Psychiatry Clin Neurosci. 2014 Sep;68(9):655-65. doi: 10.1111/pcn.12216. Epub 2014 Aug 4. Psychiatry Clin Neurosci. 2014. PMID: 24995521 Review.
Cited by
-
Elevated Plasma Protein Carbonyl Concentration Is Associated with More Abnormal White Matter in People with HIV.Viruses. 2023 Dec 12;15(12):2410. doi: 10.3390/v15122410. Viruses. 2023. PMID: 38140650 Free PMC article.
-
Immune-Inflammatory Response And Compensatory Immune-Regulatory Reflex Systems And White Matter Integrity in Schizophrenia.Schizophr Bull. 2024 Jan 1;50(1):199-209. doi: 10.1093/schbul/sbad114. Schizophr Bull. 2024. PMID: 37540273
-
Association between enhanced carbonyl stress and decreased apparent axonal density in schizophrenia by multimodal white matter imaging.Sci Rep. 2023 Jul 27;13(1):12220. doi: 10.1038/s41598-023-39379-w. Sci Rep. 2023. PMID: 37500709 Free PMC article.
-
Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives.Front Pharmacol. 2022 Oct 12;13:1005702. doi: 10.3389/fphar.2022.1005702. eCollection 2022. Front Pharmacol. 2022. PMID: 36313375 Free PMC article. Review.
-
Advanced glycation end products and cognitive impairment in schizophrenia.PLoS One. 2021 May 26;16(5):e0251283. doi: 10.1371/journal.pone.0251283. eCollection 2021. PLoS One. 2021. PMID: 34038433 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
